يعرض 1 - 10 نتائج من 26 نتيجة بحث عن '"Zemlickis, Donna"', وقت الاستعلام: 0.76s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: Nahi , H , Usmani , S Z , Mateos , M-V , van de Donk , N W C J , Oriol , A , Plesner , T , Bandyopadhyay , N , Hellemans , P , Tromp , B , Nnane , I , Zemlickis , D , Chari , A & Moreau , P 2023 , ' Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab : part 3 of the open-label, multicenter, phase 1b PAVO study ' , Leukemia and Lymphoma , vol. 64 , no. 2 ....

  2. 2
    دورية أكاديمية

    المصدر: Minchom , A , Krebs , M , Cho , B , Lee , S-H , Leighl , N , O'Neil , B , Sabari , J , Kudgus-Lokken , R , Alhadab , A , Haddish-Berhane , N , Zemlickis , D , Mitselos , A , Berkay , E , Bauml , J , Knoblauch , R , Hellemans , P & Johnson , M 2023 , ' Subcutaneous amivantamab (ami) in patients (pts) with advanced solid malignancies: The PALOMA study—Updated safety and identification of the recommended phase 2 dose. ' , Journal of Clinical Oncology , ....

  3. 3
    مؤتمر

    المصدر: Nahi , H , Usmani , S Z , Mateos , M-V , van de Donk , N W C J , Moreau , P , Oriol , A , Plesner , T , Yang , S , Hellemans , P , Tromp , B J , Luo , M , Zemlickis , D , Farnsworth , A & Chari , A 2020 , ' Corticosteriod tapering in patients (Pts) with relapsed or refractory multiple myeloma (RRMM) receiving subcutaneous daratumumab (DARA SC): Part 3 of the open-label, multicenter, phase Ib PAVO Study ' , Journal of Clinical Oncology , ....

  4. 4
    دورية أكاديمية
  5. 5
    مؤتمر

    المصدر: Nahi , H , Usmani , S Z , Mateos , M-V , van de Donk , N W C J , Moreau , P , Oriol , A , Plesner , T , Bandyopadhyay , N , Hellemans , P , Tromp , B , Nnane , I , Zemlickis , D , Farnsworth , A & Chari , A 2021 , ' Subcutaneous Daratumumab with Rapid Corticosteroid Tapering in Relapsed or Refractory Multiple Myeloma Patients: Part 3 Update of the Open-Label, Multicenter, Phase 1b Pavo Study ' , Blood , vol. 138 , no. Suppl. 1 , ....

  6. 6
    دورية أكاديمية

    المصدر: Krebs , M , Johnson , M , Cho , B , Park , K-S , Haddish , N , Zemlickis , D , Mitselos , A , Meacle , F , Knoblauch , R , Hellemans , P & Minchom , A 2021 , ' Subcutaneous delivery of amivantamab in patients with advanced solid malignancies: PALOMA, an open-label, multicenter, dose escalation phase 1b study. ' , Journal of Clinical Oncology , vol. 39 , pp. TPS3150-TPS3150 . https://doi.org/10.1200/JCO.2021.39.15_suppl.TPS3150Test

  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية

    المصدر: Medical and Pediatric Oncology ; volume 23, issue 6, page 476-479 ; ISSN 0098-1532 1096-911X

  9. 9
    دورية أكاديمية

    المصدر: Leukemia & Lymphoma ; volume 14, issue 5-6, page 411-413 ; ISSN 1042-8194 1029-2403

  10. 10
    دورية أكاديمية

    المصدر: Teratogenesis, Carcinogenesis, and Mutagenesis ; volume 13, issue 3, page 139-143 ; ISSN 0270-3211 1520-6866